EFFECTS OF THE THROMBOXANE ANTAGONIST BAY-U-3405 ON EXPERIMENTAL CORONARY-DISEASE

被引：0
|
作者：
FIEDLER, VB [1 ]
PERZBORN, E [1 ]
SEUTER, F [1 ]
机构：
[1] BAYER AG,DEPT PHARMACOL,W-5600 WUPPERTAL 1,GERMANY
来源：
CIRCULATION | 1990年 / 82卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：730 / 730
页数：1
相关论文
共 50 条
  • [31] EFFECTS OF CORONARY-DISEASE - REPLY
    PRAKASH, R
    ARONOW, WS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1976, 19 (01) : 94 - 95
  • [32] PH DEPENDENCY OF THE BINDING OF [H-3] BAY-U-3405 AND VARIOUS NON-LABELED LIGANDS TO THE THROMBOXANE-A2/PROSTAGLANDIN H-2-RECEPTOR OF HUMAN PLATELET MEMBRANES
    THEIS, JGW
    DELLWEG, H
    PERZBORN, E
    GROSS, R
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 226 (02): : 149 - 156
  • [33] THE EFFECTS OF AN ORAL THROMBOXANE TP RECEPTOR ANTAGONIST BAY U-3405, ON PROSTAGLANDIN D2-INDUCED AND HISTAMINE-INDUCED BRONCHOCONSTRICTION IN ASTHMA, AND RELATIONSHIP TO PLASMA DRUG CONCENTRATIONS
    JOHNSTON, SL
    BARDIN, PG
    HARRISON, J
    RITTER, W
    JOUBERT, JR
    HOLGATE, ST
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (05) : 402 - 408
  • [34] THE THROMBOXANE RECEPTOR ANTAGONIST BAY U3405 REVERSES PROSTAGLANDIN-D2 (PGD2)-INDUCED BRONCHOCONSTRICTION IN THE ANESTHETIZED GUINEA-PIG
    FRANCIS, HP
    MORRIS, TG
    THOMPSON, AM
    PATEL, UP
    GARDINER, PJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 629 : 399 - 401
  • [35] NEGATIVE U-WAVES IN CORONARY-DISEASE - REPLY
    SANTINELLI, V
    OPPO, I
    MATERAZZI, C
    RABUANO, A
    PISCITELLI, MM
    BASILE, F
    PALMA, M
    GIUNTA, A
    AMERICAN HEART JOURNAL, 1995, 130 (06) : 1316 - 1317
  • [36] REDUCTION OF MYOCARDIAL LEUKOCYTE ACCUMULATION AND MYOCARDIAL INFARCT SIZE FOLLOWING ADMINISTRATION OF BAY-U3405, A THROMBOXANE-A(2) RECEPTOR ANTAGONIST, IN MYOCARDIAL-ISCHEMIA REPERFUSION INJURY
    SQUADRITO, F
    IOCULANO, M
    ALTAVILLA, D
    ZINGARELLI, B
    CANALE, P
    CAMPO, GM
    SAITTA, A
    ORITI, S
    FAGGIOTTO, A
    CAPUTI, AP
    AGENTS AND ACTIONS, 1993, 39 (3-4): : 143 - 149
  • [37] EFFECTS OF VERAPAMIL ON MYOCARDIAL PERFORMANCE IN CORONARY-DISEASE
    FERLINZ, J
    EASTHOPE, JL
    ARONOW, WS
    CIRCULATION, 1979, 59 (02) : 313 - 319
  • [38] PHYSICAL-TRAINING EFFECTS IN CORONARY-DISEASE
    SILUYANOVA, VA
    IVANOV, YS
    SYRKIN, AL
    VYKHODTSEV, AN
    KOROBOVA, GA
    NURSULTANOVA, SD
    SOVETSKAYA MEDITSINA, 1985, (04): : 8 - 15
  • [39] BINDING CHARACTERISTICS OF THE NEW THROMBOXANE A2 PROSTAGLANDIN H-2-RECEPTOR ANTAGONIST [3H]BAY U-3405 TO WASHED HUMAN PLATELETS AND PLATELET MEMBRANES
    THEIS, JGW
    DELLWEG, H
    PERZBORN, E
    GROSS, R
    BIOCHEMICAL PHARMACOLOGY, 1992, 44 (03) : 495 - 503
  • [40] HEMODYNAMIC AND CORONARY EFFECTS OF RISORDAN INJECTION IN PATIENTS WITH CORONARY-DISEASE
    LELLOUCHE, D
    BENSALAH, K
    SZWARC, G
    VERNANT, P
    NOUVELLE PRESSE MEDICALE, 1982, 11 (27): : 2063 - 2070
12345